Watermark
  Back to Search Results

BGB-A317-213

Completed

Study of Tislelizumab in Participants With Resectable Esophageal Squamous Cell Carcinoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-213

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT04974047

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20211753

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents